Briganti et al. studied nine neuroblastoma tumors with 111In-pentetreotide SPECT for SST2 and found that the ratio between the radioactivity in pathological and background area was increasing between early and late acquisitions. This evidence concerns the gene SSTR2 and neuroblastoma.